Phase 1 Open-label Study of 123I-ATT001 in Subjects With Relapsed Glioblastoma

Randomized Phase 2 With CpG-ODN in Malignant Glioblastoma

NCT00190424 ·Status: COMPLETED ·Phase: PHASE2

Azeliragon and Chemoradiotherapy in Newly Diagnosed Glioblastoma

NCT05635734 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

A Study to Evaluate the Safety and Efficacy of L19TNF With Alkylating Chemotherapy for Patients With Recurrent IDH-mutant Astrocytoma or Oligodendroglioma

NCT07120984 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Clinical Trial of P134 Cells in Recurrent Glioblastoma

NCT07318818 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

131I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2)

NCT05450744 ·Status: RECRUITING ·Phase: PHASE1

Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas

NCT01721577 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma

NCT01062425 ·Status: COMPLETED ·Phase: PHASE2

Glioblastoma Treatment With Irradiation and Olaptesed Pegol (NOX-A12) in MGMT Unmethylated Patients

NCT04121455 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Safety and Efficacy of L19TNF in Patients With Isocitrate Dehydrogenase (IDH) Wildtype WHO Grade III / IV Glioma at First Relapse

NCT03779230 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study of Biologic Tumor and Plasma Biomarkers of Response to TTFields in Patients Treated for Newly Diagnosed Glioblastoma

NCT06222138 ·Status: RECRUITING ·Phase: NA

A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas

NCT00734682 ·Status: COMPLETED ·Phase: PHASE1

A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent.

NCT05109728 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Safety Study of AP23573 in Patients With Progressive or Recurrent Glioma (8669-023)(COMPLETED)

NCT00087451 ·Status: COMPLETED ·Phase: PHASE1

Study of Crenolanib, a Selective and Potent Inhibitor of PDGFR, for the Treatment of Adult Gliomas

NCT01229644 ·Status: TERMINATED ·Phase: PHASE2

Atrasentan in Treating Patients With Progressive or Recurrent Malignant Glioma

NCT00017264 ·Status: COMPLETED ·Phase: PHASE1

Low Dose Radiation Therapy for Glioblastoma Multiforme

NCT01466686 ·Status: COMPLETED ·Phase: PHASE2

CC-5013 in Treating Patients With Recurrent Glioma

NCT00036894 ·Status: COMPLETED ·Phase: PHASE1

Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomas

NCT03971734 ·Status: TERMINATED ·Phase: PHASE1

Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas

NCT01107522 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Study Evaluating the Efficacy and Safety of Selinexor (KPT-330) in Participants With Recurrent Gliomas

NCT01986348 ·Status: TERMINATED ·Phase: PHASE2

Effect of NovoTTF-100A in Recurrent Glioblastoma Multiforme (GBM)

NCT00379470 ·Status: COMPLETED ·Phase: PHASE3

A Safety Study of RTA 744 in Patients With Recurrent High-Grade Gliomas

NCT00526812 ·Status: COMPLETED ·Phase: PHASE1

Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

NCT00662506 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Biologically-based Target Volumes to Treat Newly Diagnosed Glioblastoma

NCT03506139 ·Status: WITHDRAWN ·Phase: PHASE2

Novel Targeted Radiotherapy in Pediatric Patients With Inoperable Relapsed or Refractory HGG

NCT05610891 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1